Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming

Correction to: Journal of Hematology & Oncology (2020) 13:12

https://doi.org/10.1186/s13045-019-0841-3

The original article [1] contains an error in Fig. 3c and Fig. 3g whereby the image of group WT and NC in HCCLM3 cell lines were repeated. The correct presentations of Fig. 3c and Fig. 3g can be seen ahead.

Fig. 3.

MiR-612 suppresses invasion and migration of HCC by targeting hadha. a, b Cell migration abilities and statistic results of HepG2^miR-612-KD and HCCLM3^miR-612-OE cells. Scale bars, 200 μm. c, d Cell invasion abilities and statistic results of HepG2^miR-612-KD and HCCLM3^miR-612-OE cells. Scale bars, 200 μm. e, f Cell migration abilities and statistic results of HepG2^hadha-OE and HCCLM3^hadha-KD cells. Scale bars, 200 μm. g, h Cell invasion abilities and statistic results of HepG2^hadha-OE and HCCLM3^hadha-KD cells. Cell migration abilities and statistic results of HepG2^miR-612-KD cells after hadha was knocked down. Scale bars, 200 μm. i, j Cell migration abilities and statistic results of HCCLM3 ^miR-612-OE cells after HADHA was rescued. Scale bars, 50 μm. k, l Cells (*p < 0.05; **p < 0.01). Data are mean ± SEM of three independent experiments. Scale bars, 50 μm